• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
VEMLIDY Drug Profile, 2024: VEMLIDY (tenofovir alafenamide fumarate) drug patents, FDA exclusivity, litigation, drug prices

VEMLIDY Drug Profile, 2024: VEMLIDY (tenofovir alafenamide fumarate) drug patents, FDA exclusivity, litigation, drug prices

Paperback

Series: Drugpatentwatch Business Intelligence Reports

Medical Reference

Currently unavailable to order

ISBN13: 9798875836947
Publisher: Independently Published
Published: Jan 11 2024
Pages: 132
Weight: 0.71
Height: 0.28 Width: 8.50 Depth: 11.00
Language: English
VEMLIDY Drug Profile, 2024

This report focuses on VEMLIDY and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources
FREE UPDATE: Send your receipt to DrugPatentWatch within 30 days for a free updat

Also in

Medical Reference